Shire

Shire Plc Chief Executive Officer Flemming Ornskov Interview

UPDATED: Rare Disease Drug Maker Shire’s Stock Spikes Amid Possible Bidding War Between Allergan and Takeda

By Sy Mukherjee

April 19, 2018

AbbVie Inc. To Buy Shire For $54.8 Billion

Drugmaker Shire Is Buying Baxalta for $32 Billion

January 11, 2016

AbbVie Inc. To Buy Shire For $54.8 Billion

Shire-Baxalta $32 Billion Merger Talks Said to Advance

By Michal Addady

January 3, 2016

Shire Plc's U.K. Offices As Drugmaker Rejects Abbvie Inc.'s $46.5 Billion Offer

Shire offers to buy rival drugmaker Baxalta for $30 billion

August 4, 2015

Traders At The NYSE React To Malaysian Airliner Crash In Ukraine

Markets end week with a rally, despite geopolitical turmoil

By Tom Huddleston Jr.

July 18, 2014

Fortune

Are U.S. corporate tax inversions a necessary crisis?

By Robert Litan

July 18, 2014

Most Popular